Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
Michelle V DietzKatrien L A QuintelierJob P van KootenNadine L de BoerMadelief VinkAlexandra R M Brandt-KerkhofCornelis VerhoefYvan SaeysJoachim G J V AertsMarcella WillemsenSofie Van GassenEva V E MadsenPublished in: Journal for immunotherapy of cancer (2023)
NTR7060; Dutch Trial Register (NTR).
Keyphrases
- phase ii
- clinical trial
- dendritic cells
- open label
- minimally invasive
- phase iii
- coronary artery bypass
- early stage
- regulatory t cells
- double blind
- placebo controlled
- locally advanced
- surgical site infection
- immune response
- study protocol
- metastatic renal cell carcinoma
- acute coronary syndrome
- chemotherapy induced
- percutaneous coronary intervention
- rectal cancer